Qingshan Liu - Search Results

Year	Number of Results
2005	1
2006	1
2007	5
2008	4
2009	3
2010	10
2011	11
2012	5
2013	7
2014	8
2015	9
2016	16
2017	17
2018	13
2019	14
2020	15
2021	18
2022	20
2023	24
2024	8

1

Cao J, Liu Q, Arik S, Qiu J, Jiang H, Elaiw A. Cao J, et al. Among authors: liu q. Comput Math Methods Med. 2014;2014:120280. doi: 10.1155/2014/120280. Epub 2014 Mar 6. Comput Math Methods Med. 2014. PMID: 24738006 Free PMC article. No abstract available.

2

The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.

Fan F, Liu H, Shi X, Ai Y, Liu Q, Cheng Y. Fan F, et al. Among authors: liu q. J Alzheimers Dis. 2022;85(3):1195-1204. doi: 10.3233/JAD-215423. J Alzheimers Dis. 2022. PMID: 34924395

3

The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review.

Li Y, Cui R, Fan F, Lu Y, Ai Y, Liu H, Liu S, Du Y, Qin Z, Sun W, Yu Q, Liu Q, Cheng Y. Li Y, et al. Among authors: liu q. Front Pharmacol. 2022 Jul 22;13:924747. doi: 10.3389/fphar.2022.924747. eCollection 2022. Front Pharmacol. 2022. PMID: 35935837 Free PMC article.

4

Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis.

Wei ZX, Xie GJ, Mao X, Zou XP, Liao YJ, Liu QS, Wang H, Cheng Y. Wei ZX, et al. Neuropsychopharmacology. 2020 May;45(6):1050-1058. doi: 10.1038/s41386-020-0622-2. Epub 2020 Jan 27. Neuropsychopharmacology. 2020. PMID: 31986519 Free PMC article.

5

The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review.

Li Y, Cui R, Liu S, Qin Z, Sun W, Cheng Y, Liu Q. Li Y, et al. Among authors: liu q. Front Pharmacol. 2023 Aug 24;14:1207075. doi: 10.3389/fphar.2023.1207075. eCollection 2023. Front Pharmacol. 2023. PMID: 37693907 Free PMC article.

6

Systematic review and meta-analysis on microRNAs in amyotrophic lateral sclerosis.

Liu H, Lan S, Shi XJ, Fan FC, Liu QS, Cong L, Cheng Y. Liu H, et al. Brain Res Bull. 2023 Mar;194:82-89. doi: 10.1016/j.brainresbull.2023.01.005. Epub 2023 Jan 18. Brain Res Bull. 2023. PMID: 36681253 Free article. Review.

7

Editorial: Novel therapeutic target and drug discovery for neurological diseases.

Zhao K, Li Z, Liu Q, Cheng Y, Barreto GE, Liu R. Zhao K, et al. Among authors: liu q. Front Pharmacol. 2022 Oct 7;13:1042266. doi: 10.3389/fphar.2022.1042266. eCollection 2022. Front Pharmacol. 2022. PMID: 36278216 Free PMC article. No abstract available.

8

Bergapten alleviates depression-like behavior by inhibiting cyclooxygenase 2 activity and NF-κB/MAPK signaling pathway in microglia.

Yan M, Bo X, Zhang J, Liu S, Li X, Liao Y, Liu Q, Cheng Y, Cheng J. Yan M, et al. Among authors: liu q. Exp Neurol. 2023 Jul;365:114426. doi: 10.1016/j.expneurol.2023.114426. Epub 2023 Apr 23. Exp Neurol. 2023. PMID: 37088250

9

Pose-Driven Realistic 2-D Motion Synthesis.

Xia G, Ma F, Liu Q, Zhang D. Xia G, et al. Among authors: liu q. IEEE Trans Cybern. 2023 Apr;53(4):2412-2425. doi: 10.1109/TCYB.2021.3120010. Epub 2023 Mar 16. IEEE Trans Cybern. 2023. PMID: 34673501

10

Optimization-Based Post-Training Quantization With Bit-Split and Stitching.

Wang P, Chen W, He X, Chen Q, Liu Q, Cheng J. Wang P, et al. Among authors: liu q. IEEE Trans Pattern Anal Mach Intell. 2023 Feb;45(2):2119-2135. doi: 10.1109/TPAMI.2022.3159369. Epub 2023 Jan 6. IEEE Trans Pattern Anal Mach Intell. 2023. PMID: 35290185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

173 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year